Myriad Genetics, Inc. (MYGN) Q4 2023 Earnings Call Transcript
…
5,712$
-3,03%
Echtzeit-Aktienkurs Myriad Genetics Inc.
Bid:
Ask:
Nachrichten zur Myriad Genetics Inc. Aktie
Myriad Genetics (MYGN) Q4 Earnings Top Estimate, Margins Down
Myriad Genetics (MYGN) registers a strong testing volume improvement across all its businesses in the fourth quarter of 2023.…
Myriad Genetics, Inc. 2023 Q4 - Results - Earnings Call Presentation
…
Myriad Genetics and National Cancer Center Hospital East in Japan Collaborate on Pan-Cancer MRD Monitoring Clinical Trial, SCRUM-MONSTAR-SCREEN-3
Myriad’s Precise MRD test will be used to evaluate the broad applicability of MRD testing across many cancer types Myriad’s…